A.I.M. Global Headquarters, New York — September 2010

Two weeks later, somewhere between Arthur’s newfound, quiet crusade of freeing eternally damned souls, Eileen changed the world.

Arthur sat in the fifth row of the Theodore Whitmore Convention Center, Tristan on his lap, Elena beside him. Two thousand seats, all filled. Press from forty-six countries. The biggest medical announcement of the century, and Arthur’s only job was to sit still and watch his wife work.

Nick Fury sat two seats to his left, looking deeply uncomfortable in civilian clothes. Sunglasses on. Arms crossed. The posture of a man who had been dragged to a social event against his fundamental nature.

“Remind me why I am here,” Fury grumbled, staring straight ahead.

“Because I invited you personally, Nick, and you have a soft spot for me.”

“Never. Not even in your wildest, most chemically induced dreams.”

Arthur wanted to continue the banter, but the show was starting. The house lights dimmed smoothly. The massive room settled into a heavy, expectant hush. Two thousand people leaned forward in their seats.

—

Aldrich Killian walked onto the stage like he owned it. Which, technically, he did.

The transformation from the desperate, sickly man Arthur had first invested in years ago was absolute. Tall, confident, and radiating the kind of vibrant health that made you believe whatever he was selling before he’d even said a word. Extremis had healed his old, crippling injuries and given him a striking physicality that perfectly suited the showman living inside him.

“Ladies and gentlemen,” Killian began, his voice carrying clearly across the quiet hall. “For decades, modern medicine has been heavily focused on a single, tragic goal. We manage pain. We manage deterioration. We manage loss.”

He gestured to the massive screen behind him. It blinked to life and showed a living room filled with warm light. A man sat in a wheelchair by the window, looking out at a garden he couldn’t walk in. His wife knelt beside him to adjust a blanket over legs that had not moved in years.

“Elias,” Killian said softly. “Diagnosed with ALS four years ago. Complete motor neuron degeneration.”

The screen shifted. A firefighter stared at hands wrapped heavily in bandages, knowing exactly what was underneath. His captain stood in the doorway holding a charred helmet its owner would never wear again.

“Captain David Miller. Third-degree burns over sixty percent of his body. Severe and permanent tissue damage.”

The video cut again. A teenager lay in a hospital bed with his mother asleep in the chair beside him. IV lines crisscrossed his arms. Monitors beeped steadily, measuring what little was left of a failing organ.

“Leo. Fifteen years old. Stage four liver cancer.”

The screen changed to a veteran in a physical therapy room. He was missing his left leg and a bulky prosthetic leaned against the wall. A quick clip showed his young daughter running toward him in a park, capturing the agonizing look on his face as he realized he could not run to meet her.

“Staff Sergeant Marcus Webb. IED in Kandahar, 2006.”

The final video showed a young girl sitting in a hospital wheelchair far too big for her. She was drawing. The picture showed a girl running through a field. The girl in the wheelchair was smiling, but only the girl in the picture had legs that worked.

“Sophie. Spinal cord injury at age three. Permanent paralysis.”

A heavy, emotional silence fell over the massive room. You could hear a pin drop.

“Management is a noble goal,” Killian said gently as the stage lights slowly came back up. “But at A.I.M., we decided we were entirely tired of managing symptoms. We decided it was time to rewrite the code.” He paused, looking out over the crowd. “Elias? Captain Miller? Leo? Staff Sergeant Webb? Sophie? Why don’t you come out here and show them?”

One by one, the people from the video walked out from the wings and appeared on stage. Walking. Standing. Whole. The wheelchair users walking with perfect gaits. The amputee complete with a flesh-and-blood leg. The burned man unburned, his skin flawless. The dying boy alive and glowing with health.

The murmuring in the crowd grew louder with each person who appeared. By the third person, there were loud gasps. By the fourth, open weeping.

And then came Sophie.

Eight years old. Blonde hair. She walked out from the wings slowly, carefully, each step deliberate. She held no one’s hand. She didn’t need to.

The oversized wheelchair from the video sat on the center of the stage, empty. Her parents were sitting in the front row. Her mother had both hands clamped over her mouth, sobbing openly. Her father was already crying freely, making no move to hide it.

Sophie reached center stage. She looked down at her parents and smiled brightly.

“Mum, Dad, look. I’m walking.”

Two thousand people absolutely came apart.

Arthur smiled warmly. Beside him, Elena had gone completely still, watching Sophie with intense, unwavering focus. Tristan, who had somehow migrated to Fury’s lap at some point during the emotional presentation, tugged the Director’s leather sleeve.

“Uncle Nick, why is everyone crying?”

“Because something genuinely good happened, kid,” Fury said. His voice was steady, but his jaw was ticking.

Killian wisely let the emotional moment breathe before stepping back to the sleek podium.

“We call it Extremis,” he announced, his voice ringing with triumph. “Limb regeneration. Spinal cord repair. Organ failure reversal. Severe burn recovery. Incredible effectiveness against many aggressive forms of cancer. One single course of treatment. The healing is absolute, and it is permanent.”

Dr. Maya Hansen took the stage next for the hard science. The mechanism, the clinical data, the trial results. She was thorough, precise, and scientifically airtight.

“And now, the limitations,” Maya added, because honesty was part of the presentation. “Extremis cannot address genetic conditions. Problems coded deeply into the base DNA are beyond its current reach. And the treatment does carry a biological cost to the body. Rapid cellular regeneration consumes a fraction of your natural telomeres. A full course may reduce a patient’s total life expectancy by two to three years. For the vast majority of our patients, we believe this is a trade well worth making.”

She briefly outlined the next frontier. DNA-level repair, already in active development under top scientists. “When that research matures and combines seamlessly with Extremis,” Maya said confidently, “we firmly believe conditions that modern medicine has called ‘incurable’ will finally have an expiration date.”

Then Killian returned to the podium for the killing blow.

“This is not a pipe dream. Everything we showed you today is real, and it is ready. Extremis is truly magical.” He let the room settle into a tense hush. “And now, the thing on everyone’s mind. The price.”

Two thousand people held their collective breath.

“Fifty thousand dollars.”

The applause was explosive. Mixed within it, however, was the distinct look of absolute terror on the faces of the pharmaceutical representatives.

Fifty thousand dollars shattered every model they had built. At that price, Extremis didn’t compete with existing procedures. It replaced them. Why pay three hundred thousand for an organ transplant with years of immunosuppressants when Extremis could regenerate the organ for a sixth of the cost? Why spend half a million on experimental spinal treatments when fifty thousand fixed it permanently?

The pharmaceutical representatives reached for their phones. Some were already pale. A few looked physically ill. They had walked into this room expecting a new competitor and had just discovered an extinction-level event.

“It is exactly at cost. Zero profit margin,” Killian continued, his voice cutting over the noise. “The primary goal of Extremis is not to make A.I.M. rich. The goal is to make human suffering optional.”

During the massive standing ovation, Fury leaned heavily toward Arthur, raising his voice over the cheering. “Fifty thousand. You know exactly what this does to the global pharmaceutical industry.”

“Destroys it,” Arthur said comfortably. “Slowly, then all at once.”

“You really do enjoy making dangerous enemies. First the Phoenix Group disrupting finance and tech, now this. You’re burning massive holes in the pockets of very, very powerful people, Hayes. One day they’ll have enough and react without considering the consequences.”

“Sounds like a you problem, Nick.”

Fury grunted. “Can’t you at least leave them some crumbs? Maybe do a public IPO, let the big players have a piece of something to keep them docile?”

“Forget about them. Let’s talk about you, Fury.”

“Me?”

“Yes. Interested in a dose of Extremis? Maybe regrow that missing eye.”

“Don’t know. I feel the eye patch looks great on me. Adds a necessary intimidation factor.” He glanced down at Elena, who was still cheering. “What do you think, Ele?”

Elena looked up. “The patch makes you look like a pirate, Uncle Fury. But did you really lose your eye to a cat?”

The temperature around Fury dropped several degrees. He turned to Arthur with a look that promised future retribution.

“Your dad loves his tall tales, Ele. Don’t believe them. A Flerken took my eye. It is a very dangerous, highly classified alien creature. Not a cat.”

Elena turned to Arthur. “Dad, is Uncle Fury right? Did you tell a lie?”

“No, sweetheart. Your uncle is the one bending the truth. I have actual video proof of a chubby orange cat scratching Uncle Fury right in the eye.”

“Arthur…” Fury warned, his voice dangerously low.

“Moving on. Do you want the Extremis treatment or not?”

“This is not over, Hayes.” Fury let the threat hang heavily in the air for a moment, then continued. “I wouldn’t say no to the enhancement version. The one you’re not selling to the public.”

Arthur looked at him sideways. “How do you know about the enhancement version?”

“I’m the Director of SHIELD. It’s my job to know things you want hidden.”

“Not possible. I’ve made sure no spy got anywhere near A.I.M. Did Tony tell you?”

“Stark couldn’t keep a secret from me if his life depended on it. I asked him a few pointed questions about his improved physique after he lost the hole in his chest. He tried to dodge. Terrible liar when he’s not performing for cameras.”

“Was he angry when he figured out you’d tricked him?”

“You tell me. He hasn’t sent me a single update on his Kree tech research in over a month.”

“So… very angry.”

“Extremely angry. It’s been refreshing, actually. A nice, quiet month.” Fury paused, adjusting his sunglasses. “So. About my enhancement.”

“Go to Killian directly after the event. I’ll let him know you’re coming.”

“Appreciated.”

“Can’t have the Director of SHIELD being the weakest person at SHIELD, can we?”

Fury’s head turned slowly. “I am not the weakest person at SHIELD.”

“Fought anyone lately? Old age and a cushy desk job do tend to dull one’s edge.”

—

The press Q&A began well. Killian fielded the initial questions with easy charm, deftly deferring to Maya for technical details and to the glowing patients for personal testimony.

Fifteen minutes in, a sharply dressed journalist in the fourth row stood up.

“Mr. Killian, your human trials began only in January of this year. That’s an extraordinarily compressed timeline from first human trial to public launch. Eight months. Most treatments take years, sometimes decades. Can you address concerns about long-term effects that simply haven’t had time to manifest?”

It was a fair, expected question. The room leaned in. Killian looked to the side of the stage, and Eileen stepped smoothly forward to the microphone.

This was her domain. The tough questions were always going to be hers.

“That’s an excellent question,” Eileen said, taking the podium. “And it deserves a thorough answer.”

She didn’t rush. Didn’t get defensive.

“It is entirely true that our first human trial began in January 2010. What you aren’t seeing is the nearly ten years of exhaustive animal trials that preceded it. The thermal anomalies some of you may have heard rumors about were real. They occurred in our very early animal testing phases, years ago.”

She looked directly at the press pool.

“That is exactly why we spent a decade perfecting the formula before a single human being ever received Extremis. We were ruthlessly conservative. By the time we moved to human trials in January 2010, the compound was completely stabilized. Across all phases of our human trials, we have had zero adverse effects. Zero. The data is public, peer-reviewed, and available for any researcher or regulator to examine on our website.”

She paused.

“As for the compressed timeline from trial to launch, the answer is simple. When your treatment works and your safety data is clean, the only reason to delay is caution. And there is a difference between reasonable caution and unnecessary delay. Every month we wait, people who could be walking are sitting in wheelchairs. People who could be whole are living without limbs. We chose to move as quickly as safety allowed because the people who need this treatment have already waited long enough.”

The audience murmured in approval. A perfect and bulletproof rebuttal.

But then another woman stood up near the back. Mid-thirties. Professionally dressed. Her composure was a little too studied, her timing a little too convenient.

“Sarah Chen, independent media,” she said loudly. “Ms. Hayes, thank you for that explanation. However, I have information from a source inside A.I.M. that contradicts your public data.”

The room shifted.

“My source, a former senior employee who left the company under a strict non-disclosure agreement, has provided documentation showing that during human trials, at least three subjects experienced catastrophic cellular degeneration. Rapid aging. One subject reportedly died when the treatment destabilized completely.” She held up a sleek tablet. “I have internal communications and lab reports supporting these claims right here. Given the severity of these allegations, I am formally requesting that federal regulatory authorities conduct an independent, unannounced search of A.I.M.’s facilities and databases to verify the integrity of your trial data.”

The room erupted into tense whispers. Cameras pivoted toward the woman.

Eileen stood at the podium. She didn’t flinch. Didn’t look at Killian. Didn’t look at Maya.

She looked at Arthur, who looked like he had just returned from a short adventure.

Fury stared at Arthur. “Where the hell did you just go?”

“Captured some pesky intruders,” Arthur whispered back. “Eileen will announce everything in a moment.”

On stage, Eileen felt her tablet vibrate. She glanced down and read the screen for exactly three seconds. When she looked back up at the woman, the polite warmth was entirely gone.

“You know, Ms. Chen,” Eileen said, her voice cutting through the murmurs like a blade. “Or should I say, Rebecca Marsh. Because that is your real name. You are a hired actress from Atlanta.”

The woman froze.

“You are absolutely right about one thing,” Eileen continued, stepping out from behind the podium. “There are files detailing thermal explosions and rapid aging on our servers. Or rather, there were. They were being uploaded about thirty seconds ago by three mercenaries hired through Greystone Security Solutions.”

The room went dead silent.

“Those mercenaries,” Eileen said with cold precision, “were contracted by the law firm Harwick and Associates, acting on behalf of a consortium of six pharmaceutical companies operating under the shell entity Stonebridge Health Solutions.”

She pointed directly at the nearest camera.

“Companies that charge hundreds of thousands of dollars for procedures that Extremis renders obsolete spent millions today trying to frame us. They planted fabricated evidence on our servers so that when you called for a federal raid, the authorities would find exactly what you promised them.”

The fake journalist sank slowly into her chair, her face completely ashen. Convention security arrived moments later and quietly escorted her from her seat. Her fate, and the fate of the companies that hired her, was utterly sealed.

“Extremis works,” Eileen declared. Her voice echoed through the hall. “It is safe. It costs fifty thousand dollars. And absolutely no amount of corporate sabotage, planted evidence, or hired actors will stop us from giving it to the world.”

She turned on her heel and walked off the stage.

The ensuing ovation didn’t just rattle the walls. It shook the foundations. Four unbroken minutes of a standing, deafening roar.

Fury watched the crowd rise to its feet, then slowly turned his head to look at Arthur.

“Your wife is terrifying when she’s angry.”

“I know.” Arthur smiled proudly. “Isn’t she wonderful? She gets like that when anyone tries to stop her from helping people.”

“Wonderful. That’s one way to put it.” Fury straightened his blazer, looking slightly unnerved. “Set up the enhancement for me. Quickly.”

“Already done, Nick.”

Source: Webnovel.com, updated by NovelKeep